Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Revenue (2021 - 2023)

Senti Biosciences has reported Revenue over the past 3 years, most recently at $338000.0 for Q3 2023.

  • For Q3 2023, Revenue fell 77.7% year-over-year to $338000.0; the TTM value through Jun 2024 reached $338000.0, down 89.75%, while the annual FY2025 figure was $22000.0, N/A changed from the prior year.
  • Revenue for Q3 2023 was $338000.0 at Senti Biosciences, down from $687000.0 in the prior quarter.
  • Over five years, Revenue peaked at $1.5 million in Q3 2022 and troughed at -$191000.0 in Q4 2022.
  • A 3-year average of $852200.0 and a median of $948000.0 in 2021 define the central range for Revenue.
  • On a YoY basis, Revenue climbed as much as 42.42% in 2022 and fell as far as 124.09% in 2022.
  • Year by year, Revenue stood at $793000.0 in 2021, then tumbled by 124.09% to -$191000.0 in 2022, then soared by 276.96% to $338000.0 in 2023.
  • Business Quant data shows Revenue for SNTI at $338000.0 in Q3 2023, $687000.0 in Q2 2023, and $1.3 million in Q1 2023.